Elevated blood pressure among U.S. adults with diabetes, 1988-1994.
暂无分享,去创建一个
Michael M Engelgau | Deborah B Rolka | M. Engelgau | L. Geiss | Linda S Geiss | D. Rolka | Deborah B. Rolka
[1] P Whelton,et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.
[2] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[3] C. Lowy. Diabetes and hypertension. , 1978, Lancet.
[4] D. Siegel,et al. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure. , 1997, JAMA.
[5] J. Sowers,et al. Diabetes mellitus and hypertension. , 1992, Hypertension.
[6] J. Tuomilehto,et al. Physicians’ opinions about the management of hypertension: changes in Finland between 1985 and 1992 , 1998, Journal of Human Hypertension.
[7] J. Cutler,et al. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. , 1988, Archives of internal medicine.
[8] M. Brown,et al. Influence of age on general practitioners' definition and treatment of hypertension , 1995, BMJ.
[9] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[10] S. Mehta,et al. Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP). , 1999, American journal of hypertension.
[11] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[12] H. Black,et al. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2000, Archives of internal medicine.
[13] Philip D. Harvey,et al. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 , 1998, BMJ.
[14] A. Coca. Actual blood pressure control: are we doing things right? , 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[15] National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. , 1993, Archives of internal medicine.
[16] James M. Wright,et al. Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia , 1998, The Lancet.
[17] Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .
[19] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[20] C. Bulpitt,et al. Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .
[21] John S Yudkin,et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.
[22] B Barnwell,et al. SUDAAN User's Manual, Release 7.5, , 1997 .
[23] C. Fox. Diabetes and hypertension: an era of clarity or confusion? , 1999, Journal of Human Hypertension.
[24] G. Bakris,et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[26] V. Pavlik,et al. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. , 2000, Archives of internal medicine.
[27] David Siegel,et al. Trends in Antihypertensive Drug Use in the United States: Do the JNC V Recommendations Affect Prescribing? , 1997 .
[28] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[29] L. Appel,et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. , 1999, Archives of internal medicine.
[30] H. Black,et al. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. , 2000, Hypertension.
[31] Ward Hj,et al. Inadequate management of blood pressure in a hypertensive population. , 1999 .